Interestingly, as MM-BMSCs are able to suppress miR-15a expression, they provide survival support and protect MM cells from bortezomib-induced apoptosis, as they block repression of bortezomib downstream targets (VEGF, cyclin D, Bcl-2; Fig.5) [69]. The gene discussed is VEGFA; the disease is Miyoshi myopathy.